This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent. Top assignees: Rutgers, The State University of New Jersey, The Feinstein Institutes for Medical Research. Active years: 2021-2025.
Company Filing History:
3 out of 1,494 
1 out of 162 Years Active: 2021-2025
Title: Betsy J Barnes: Innovator in Autoimmune Disease Treatment
Introduction
Betsy J Barnes is a prominent inventor based in Glenwood Landing, NY (US). She has made significant contributions to the field of medical research, particularly in the treatment of autoimmune and inflammatory diseases. With a total of 4 patents, her work has the potential to impact many lives.
Latest Patents
Betsy J Barnes holds several notable patents. One of her latest inventions is related to interferon regulatory factor 5 inhibitors and their uses. This patent discloses polypeptides that comprise a cell-penetrating amino acid sequence and an interferon regulatory factor 5 (IRF5) targeting amino acid sequence. The IRF5 targeting amino acid sequences include RHATRHG (SEQ ID NO:1), KSRDFRL (SEQ ID NO:2), and GPRDMPP (SEQ ID NO:3). These polypeptides can be used to treat diseases, including autoimmune and inflammatory conditions. Another significant patent focuses on cell-penetrating peptides that inhibit IRF5 nuclear localization. This invention provides inhibitors of IRF5 nuclear localization and methods for using these inhibitors to treat autoimmune diseases such as systemic lupus erythematosus (SLE).
Career Highlights
Throughout her career, Betsy has worked with esteemed institutions, including Rutgers, the State University of New Jersey, and The Feinstein Institutes for Medical Research. Her research has been pivotal in advancing the understanding and treatment of autoimmune diseases.
Collaborations
Betsy has collaborated with notable colleagues, including Shan Sun. These partnerships have further enriched her research and contributed to her innovative work.
Conclusion
Betsy J Barnes is a dedicated inventor whose work in the field of autoimmune disease treatment showcases her commitment to improving health outcomes. Her patents reflect her innovative spirit and the potential to make a significant impact in medical research.